Design Considerations for Macroencapsulation Devices for Stem Cell Derived Islets for the Treatment of Type 1 Diabetes

Stem cell derived insulin producing cells or islets have shown promise in reversing Type 1 Diabetes (T1D), yet successful transplantation currently necessitates long‐term modulation with immunosuppressant drugs. An alternative approach to avoiding this immune response is to utilize an islet macroenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Goswami, Debkalpa, Domingo‐Lopez, Daniel A., Ward, Niamh A., Millman, Jeffrey R., Duffy, Garry P., Dolan, Eimear B., Roche, Ellen T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373111/
https://www.ncbi.nlm.nih.gov/pubmed/34155834
http://dx.doi.org/10.1002/advs.202100820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373111/
https://www.ncbi.nlm.nih.gov/pubmed/34155834
http://dx.doi.org/10.1002/advs.202100820

Ejemplares similares